Products
15884 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genmab Constant Leverage with ISIN code: CH1423417562 | Genmab | Constant Leverage | Long | ― | 1,661.132 | 1.53 | 0.040 | 1.57 | 1 | -2.55% | -23.12% | -69.34% | 13 Jun. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1450969170 | Genmab | Constant Leverage | Long | ― | 1,661.132 | 5.37 | 0.100 | 5.47 | 1 | -1.83% | -17.13% | -56.31% | 21 Aug. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1450969451 | Genmab | Constant Leverage | Long | ― | 1,661.132 | 2.34 | 0.050 | 2.39 | 1 | -2.09% | -17.31% | -56.42% | 15 Sep. 2025 | |
| Genmab Constant Leverage with ISIN code: CH1345999051 | Genmab | Constant Leverage | Short | ― | 1,661.132 | 0.46 | 0.030 | 0.49 | 1 | -6.12% | 9.52% | 53.33% | 18 Apr. 2024 | |
| Genmab Constant Leverage with ISIN code: CH1119068372 | Genmab | Constant Leverage | Short | ― | 1,661.132 | 0.72 | 0.030 | 0.75 | 1 | -4.00% | 7.46% | 35.85% | 18 May. 2022 | |
| Genmab Constant Leverage with ISIN code: CH1396328994 | Genmab | Constant Leverage | Short | ― | 1,661.132 | 0.16 | 0.030 | 0.19 | 1 | -15.79% | 0.00% | 61.62% | 12 Feb. 2025 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1197223048 | Gilead Sciences | Constant Leverage | Long | ― | 141.199 | 10.83 | 0.030 | 10.86 | 1 | -0.28% | -16.82% | -37.87% | 24 Jun. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1119067762 | Gilead Sciences | Constant Leverage | Long | ― | 141.199 | 28.15 | 0.060 | 28.21 | 1 | -0.21% | -11.51% | -25.49% | 11 May. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1197223055 | Gilead Sciences | Constant Leverage | Long | ― | 141.199 | 0.91 | 0.010 | 0.92 | 1 | -1.09% | -22.22% | -49.16% | 24 Jun. 2022 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1450968131 | Gilead Sciences | Constant Leverage | Short | ― | 141.199 | 0.5 | 0.010 | 0.51 | 1 | -1.96% | 13.64% | 31.58% | 9 Jul. 2025 | |
| Gilead Sciences Constant Leverage with ISIN code: CH1450968149 | Gilead Sciences | Constant Leverage | Short | ― | 141.199 | 1.68 | 0.010 | 1.69 | 1 | -0.59% | 10.53% | 26.32% | 9 Jul. 2025 | |
| Givaudan Constant Leverage with ISIN code: CH1119066574 | Givaudan | Constant Leverage | Long | ― | 2,725.287 | 0.64 | 0.030 | 0.67 | 1 | -4.48% | -12.33% | -38.46% | 27 Apr. 2022 | |
| Givaudan Constant Leverage with ISIN code: CH1423416499 | Givaudan | Constant Leverage | Long | ― | 2,725.287 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -75.00% | 12 May. 2025 | |
| Givaudan Constant Leverage with ISIN code: CH1197221224 | Givaudan | Constant Leverage | Long | ― | 2,725.287 | 0.13 | 0.030 | 0.16 | 1 | -18.75% | -31.58% | -55.17% | 15 Jun. 2022 | |
| Givaudan Constant Leverage with ISIN code: CH1423416481 | Givaudan | Constant Leverage | Short | ― | 2,725.287 | 48.19 | 2.530 | 50.72 | 1 | -4.99% | 12.20% | 109.80% | 12 May. 2025 | |
| Givaudan Constant Leverage with ISIN code: CH1450968792 | Givaudan | Constant Leverage | Short | ― | 2,725.287 | 18.16 | 0.950 | 19.11 | 1 | -4.97% | 12.24% | 109.94% | 21 Aug. 2025 | |
| Givaudan Constant Leverage with ISIN code: CH1362350212 | Givaudan | Constant Leverage | Short | ― | 2,725.287 | 19.23 | 0.630 | 19.86 | 1 | -3.17% | 8.16% | 63.94% | 12 Aug. 2024 | |
| Givaudan Constant Leverage with ISIN code: CH1290994222 | Givaudan | Constant Leverage | Short | ― | 2,725.287 | 5.02 | 0.210 | 5.23 | 1 | -4.02% | 10.33% | 86.62% | 18 Apr. 2024 | |
| Givaudan Constant Leverage with ISIN code: CH1423416473 | Givaudan | Constant Leverage | Short | ― | 2,725.287 | 42.71 | 3.310 | 46.02 | 1 | -7.19% | 11.95% | 153.02% | 12 May. 2025 | |
| Givaudan Constant Leverage with ISIN code: CH1450968784 | Givaudan | Constant Leverage | Short | ― | 2,725.287 | 14.55 | 1.130 | 15.68 | 1 | -7.21% | 11.92% | 153.04% | 21 Aug. 2025 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.